欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4615/001
药品名称Streflam, 8.75 mg
活性成分
    • flurbiprofen 8.75 mg
剂型Lozenge
上市许可持有人RECKITT BENCKISER HEALTHCARE (UK) LTD. Jennifer Smith
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 00063/0644 - 0020
    • Germany (DE)
      Flurbiprofen RB zuckerfrei 8,75 mg Lutschtabletten
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Austria (AT)
      Flurbiprofen Reckitt Benckiser 8,75 mg Lutschtabletten
    • Spain (ES)
    • Greece (GR)
    • Iceland (IS)
    • Sweden (SE)
    • Portugal (PT)
      PL 00063/0644 - 0020
    • Finland (FI)
    • Lithuania (LT)
      Strepflam 8,75 mg kietosios pastilės
    • Estonia (EE)
      STREPSILS INTENSIVE ORANGE 8,75MG LOSENGID (SUHKRUVABA)
    • Cyprus (CY)
      STREPFLAM LOZENGES
    • Slovenia (SI)
许可日期2012/06/18
最近更新日期2024/04/19
药物ATC编码
    • M01AE09 flurbiprofen
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase